CAR T-Cell Therapy in Multiple Myeloma : Episode 1
Navigating the Myeloma Journey: Insights from Diagnosis to First-Line Treatment in Standard-Risk Patient
Panelists discuss how the patient’s journey with multiple myeloma begins with an initial diagnosis followed by first-line treatments and how this informs the decision to consider chimeric antigen receptor T-cell therapy as a subsequent option in their treatment path.
Video content above is prompted by the following:
Can you share your journey with multiple myeloma, starting with your initial diagnosis and first-line treatment?
Recent Videos
Related Content
